MedTrace Logo

Laparoscopic Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy

NCT02203409 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-01-14

No results posted yet for this study

Summary

The purpose of this research is evaluate the results with laparoscopic ALPPS procedure in a single center. The validity, feasibility and limitations were assessed objectively through our clinical prospective study.The investigators expect laparoscopic ALPPS is safe, effective and feasible.

Conditions

  • Liver Tumor

Interventions

PROCEDURE

Laparoscopic ALPPS

Laparoscopic Associating Liver Partition and Portal Vein Ligation for Two-stage Hepatectomy

Sponsors & Collaborators

  • Shuguo Zheng, MD

    lead OTHER

Principal Investigators

  • Shuguo Zheng · Institute of Hepatobiliary Surgery ,Southwest Hospital ,Third Military Medical University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02203409 on ClinicalTrials.gov